Beijing Sl Pharmaceutical Co.,Ltd.’s Net Profit Rose 93.7% in First Half of 2023

Beijing Sl Pharmaceutical Co.,Ltd. (北京双鹭药业股份有限公司) (002038.SZ) reported a net profit of 316.2 million yuan in the first half of 2023, up 93.7% year-on-year.

Meanwhile, the company posted 583.5 million yuan in revenue, up 5.3% year-on-year.

At the end of the reporting period, it had 6.1 billion yuan in total assets and 394.1 million yuan in total liabilities, with a liability-to-asset ratio of 6.5%.